Form 4 for STE Steris
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001628280-25-029688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-03 | STE | Madsen Julia | SVP, GM, Life Sciences | A - Grant | $0.00 | +1,998 | 11.0K | +22% | $0 |
| D | 2025-06-05 | 2025-06-03 | STE | Madsen Julia | SVP, GM, Life Sciences | A - Grant | $0.00 | +7,100 | 7,100 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-03 | A | A | 1,998 | $0.00 | 10,956 | D | — | — | (F1) As of June 3, 2025, 4,689 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-06-03 | A | A | 7,100 | $0.00 | 7,100 | D | $267.66 · — to 2035-06-03 | 7,100 Ordinary Shares | (F2) This option becomes exercisable as follows: 1,775 on June 3, 2026, 1,775 on June 3, 2027, 1,775 on June 5, 2028 and 1,775 on June 4, 2029. |